A study has found that the incidence of inflammatory skin diseases is higher in affluent areas. According to the New York ...

Researchers have found in a new study published in Diabetes Research and Clinical Practice that prior psoriasis in patients with type 2 diabetes mellitus (T2DM) is associated with a ...

Arcutis Biotherapeutics surges on strong Q3 results, Zoryve growth, and a bullish FY 2026 outlook. Click here to find out why ...

Sun Pharma introduces Ilumya in India for treatment of moderate-to-severe plaque psoriasis: Our Bureau, Mumbai Tuesday, December 2, 2025, 14:45 Hrs [IST] Sun Pharma has announced ...

While we don’t face snow, ice, and brutally cold temperatures in our Havasu oasis, winter brings a calm beauty—quiet mornings ...

For skin that can stand up to rough conditions and heal quickly — especially in winter, you need to build skin resilience, ...

Though patients with psoriasis (PsO) or psoriatic arthritis (PsA) face an elevated risk for major adverse cardiac events (MACE), the likelihood of developing these events does not significantly differ ...

Mycosis fungoides is the most common subtype, making up the vast majority of CTCL cases. While early-stage disease has an estimated five-year survival rate of 88%, it remains a difficult-to-manage ...

A new epidemiological study from Lund University in Sweden suggests that tattoos could be a risk factor for melanoma.

Scinai Immunotherapeutics Ltd. ("Scinai", or the "Company"), a biopharmaceutical company developing innovative inflammation and immunology (I&I) therapeutics and operating a growing boutique CDMO ...

LAMPASAS, Texas, Dec. 2, 2025 /PRNewswire/ -- U.S. Dermatology Partners is pleased to announce the opening of its new office in Lampasas, Texas. This is the first dedicated dermatology clinic to serve ...